As of close of business last night, Alpine Immune Sciences Inc’s stock clocked out at $38.55, up 2.88% from its previous closing price of $37.47. In other words, the price has increased by $+1.08 from its previous closing price. On the day, 719710 shares were traded.
Ratios:
To gain a deeper understanding of ALPN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 3.81. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $44.
On October 18, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $18.
On October 17, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $18.Berenberg initiated its Buy rating on October 17, 2023, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 26 ’24 when Rickey James Paul sold 117,764 shares for $23.32 per share. The transaction valued at 2,745,830 led to the insider holds 0 shares of the business.
Rickey James Paul sold 236 shares of ALPN for $5,192 on Jan 25 ’24. The insider now owns 0 shares after completing the transaction at $22.00 per share. On Dec 28 ’23, another insider, Thompson Peter A., who serves as the Director of the company, sold 1,364,849 shares for $18.35 each. As a result, the insider received 25,049,034 and left with 264,315 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALPN now has a Market Capitalization of 2.53B and an Enterprise Value of 2.34B. For the stock, the TTM Price-to-Sale (P/S) ratio is 82.03 while its Price-to-Book (P/B) ratio in mrq is 11.75. Its current Enterprise Value per Revenue stands at 76.08 whereas that against EBITDA is -42.07.
Stock Price History:
Over the past 52 weeks, ALPN has reached a high of $38.02, while it has fallen to a 52-week low of $6.39. The 50-Day Moving Average of the stock is 25.51, while the 200-Day Moving Average is calculated to be 15.63.
Shares Statistics:
It appears that ALPN traded 1.01M shares on average per day over the past three months and 971.79k shares per day over the past ten days. A total of 45.98M shares are outstanding, with a floating share count of 44.64M. Insiders hold about 31.88% of the company’s shares, while institutions hold 68.33% stake in the company. Shares short for ALPN as of Feb 15, 2024 were 4.03M with a Short Ratio of 4.00, compared to 2.41M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.15% and a Short% of Float of 10.03%.
